Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Randomized to Study Drug	STARTED	Ipilimumab 10mg/kg	475
Randomized to Study Drug	STARTED	Placebo	476
Randomized to Study Drug	COMPLETED	Ipilimumab 10mg/kg	471
Randomized to Study Drug	COMPLETED	Placebo	474
Randomized to Study Drug	NOT COMPLETED	Ipilimumab 10mg/kg	4
Randomized to Study Drug	NOT COMPLETED	Placebo	2
Treated With Study Drug	STARTED	Ipilimumab 10mg/kg	471
Treated With Study Drug	STARTED	Placebo	474
Treated With Study Drug	COMPLETED	Ipilimumab 10mg/kg	63
Treated With Study Drug	COMPLETED	Placebo	143
Treated With Study Drug	NOT COMPLETED	Ipilimumab 10mg/kg	408
Treated With Study Drug	NOT COMPLETED	Placebo	331
Long Term Follow-Up	STARTED	Ipilimumab 10mg/kg	141
Long Term Follow-Up	STARTED	Placebo	143
Long Term Follow-Up	COMPLETED	Ipilimumab 10mg/kg	130
Long Term Follow-Up	COMPLETED	Placebo	129
Long Term Follow-Up	NOT COMPLETED	Ipilimumab 10mg/kg	11
Long Term Follow-Up	NOT COMPLETED	Placebo	14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00636168/flow